LSL Pharma Group (TSXV:LSL) ROCE % : 2.94% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. LSL Pharma Group's annualized ROCE % for the quarter that ended in Dec. 2023 was 2.94%.

LSL Pharma Group ROCE % Historical Data

The historical data trend for LSL Pharma Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group ROCE % Chart

LSL Pharma Group Annual Data

Trend

Sep20

Dec21

Dec22

Dec23

ROCE %

5.16

-0.25

-36.26

-43.79

LSL Pharma Group Quarterly Data
	Sep20	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial							-57.32	-75.82	-55.91	-9.39	2.94

LSL Pharma Group ROCE % Calculation

LSL Pharma Group's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-6.902	/	( ( (27.312 - 11.618)	+	(30.9 - 15.074) )	/ 2 )
	=	-6.902	/	( (15.694	+	15.826)	/ 2 )
	=	-6.902	/	15.76
	=	-43.79 %

LSL Pharma Group's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	0.46	/	( ( (29.653 - 14.235)	+	(30.9 - 15.074) )	/ 2 )
	=	0.46	/	( ( 15.418	+	15.826 )	/ 2 )
	=	0.46	/	15.622
	=	2.94 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

LSL Pharma Group (TSXV:LSL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

LSL Pharma Group ROCE % Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

LSL Pharma Group (TSXV:LSL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3030, Le Carrefour Boulevard, Suite 1002, Laval, QC, CAN, H7T 2P5

Website

LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group (TSXV:LSL) Headlines

No Headlines